Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Alexander MM Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, Wim HJ Kruit, Jeremy Marsden, Cornelis JA Punt, Francois Sales, Martin Gore, Rona MacKie, Zvonko Kusic, Reinhard Dummer, Axel Hauschild, Elena Musat, Alain Spatz, Ulrich Keilholz